CSIMarket
 
Pfizer Inc  (PFE)
Other Ticker:  
 
 
Price: $40.1500 $-0.53 -1.303%
Day's High: $40.67 Week Perf: 2.98 %
Day's Low: $ 39.95 30 Day Perf: 1.16 %
Volume (M): 21,387 52 Wk High: $ 43.08
Volume (M$): $ 858,684 52 Wk Avg: $36.95
Open: $40.66 52 Wk Low: $31.61



 Market Capitalization (Millions $) 227,329
 Shares Outstanding (Millions) 5,662
 Employees 88,300
 Revenues (TTM) (Millions $) 50,198
 Net Income (TTM) (Millions $) 11,127
 Cash Flow (TTM) (Millions $) -386
 Capital Exp. (TTM) (Millions $) 2,850

Pfizer Inc
Pfizer Inc., is a research-based, global pharmaceutical company. We discover, develop, manufacture and market leading prescription medicines for humans and animals as well as many of the world’s best-known consumer healthcare products. The Company was incorporated under the laws of the State of Delaware on June  2, 1942.


   Company Address: 235 East 42nd Street New York 10017 NY
   Company Phone Number: 733-2323   Stock Exchange / Ticker: NYSE PFE
   PFE is expected to report next financial results on February 24, 2022. Next quarterly dividend pay out on September 01, 2021.


Customers Net Income grew by PFE's customers Net margin grew to

7.22 %

4.89 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
MRK        2.91% 
LLY        10.92% 
JNJ   -0.61%    
BMY        3.7% 
ABT        0.57% 
ABBV        2.72% 
• View Complete Report
   



Gsi Technology Inc

Gsi Technology Inc announced fiscal period ending Mar 31 2021 operating deficit of $-5.265 millions

Lower demand led to lower revenues and higher loss, in the fiscal period ending Mar 31 2021 company loss increased to $-0.21 per share, while Sales fell by -9.95% to $7.69 millions, year on year.

In the previous quarter company realized Sales of $6.76 millions and bottom line of $-0.22 per share.
Gsi Technology Inc reported net loss of $-21.51 millions and Sales of $27.73 millions for the fiscal year 2021.

Net loss per share has widen to $-0.91 from $-0.45 in previous fiscal year, while Sales Tumbled by -36.02 % from $43.34 millions a year ago.

Vaso Corp

Break-even, Sales Lower

In the first quarter of 2021 Vaso Corp reached break-even of $0.00 per share compared to $-0.01 a year ago and from $0.00 per share from the previous quarter.

Sales contracted by -4.42% to $16.52 millions from $17.28 millions in the same quarter a year ago and sequentially Sales deteriorated by -11.63% from $18.69 millions.

Village Super Market Inc

Decline in Earnings despite Increase in Demand

Village Super Market Inc reported declining eps on increasing revenue in the third quarter of 2021, where Sales grew by 4.98% to $481.09 millions in comparison to $458.29 millions on a year-over-year basis, while eps dived by -76.62% to $0.18 per share, income per share was $0.77 in the same quarter a year ago.

In the previous quarter company realized Sales of $522.82 millions and bottom line of $0.31 per share.

L Brands Inc

L Brands Inc announced fiscal first quarter of 2021 operating surplus of $572 millions

L Brands Inc announced earnings per share of $0.97 and Sales of $3.21 billions in the fiscal first quarter of 2021, Company's earnings turn positive per share, versus $-0.91 eps, earned in the same quarter a year ago, although L Brands Inc saw its Sales rise by 12.96% in the same period.

From the preceding quarter, profit plummeted by -60.76% from $2.47 per share and Sales decreased by -5.88% from $3.21 billions.

The Toro Company

The Toro Company announced second quarter of 2021 operating income of $180.716 millions

The Toro Company announced strong results in the second quarter of 2021, where Sales rose by 23.64% to $1.15 billions and profits soared by 43.96 % to $1.31 per share, year on year.

Sequentially earnings grew by 28.43 % from $1.02 per share and Sales surged by 31.63 % from $872.99 millions.






 

Pfizer Inc's Segments
 
Cardiovascular & metabolic diseases
 Segment    7.34 % of total Revenue
Central nervous system disorders
 Segment    1.23 % of total Revenue
Arthritis & pain
 Segment    1.62 % of total Revenue
Infectious & respiratory diseases
 Segment    4.91 % of total Revenue
Urology
 Segment    2.55 % of total Revenue
Oncology
 Segment    2.14 % of total Revenue
Ophthalmology
 Segment    0.75 % of total Revenue
Endocrine disorders
 Segment    1.09 % of total Revenue
All other
 Segment    69.99 % of total Revenue
Total Pharmaceutical
 Segment    91.61 % of total Revenue
Consumer Healthcare and Vaccines
 Segment    6.25 % of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Pfizer Inc does not provide revenue guidance.

Earnings Outlook
The Toro Company does not provide earnings estimates.

 
Geographic Revenue Dispersion
United States 38.45 %
Other 37.93 %
Europe 23.62 %


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WATT's Profile

Stock Price

WATT's Financials

Business Description

Fundamentals

Charts & Quotes

WATT's News

Suppliers

WATT's Competitors

Customers & Markets

Economic Indicators

WATT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071